Measurement of epidermal growth factor receptor turnover and effects of Cdc42

Qiong Lin1, Wannian Yang, Richard A Cerione

  • 1Weis Center for Research, Geisinger Clinic, Danville, PA, USA.

Methods in Enzymology
|February 14, 2006
PubMed

Insights

This study details methods for measuring epidermal growth factor receptor (EGFR) degradation, a key process in cell signaling. It investigates the role of Cdc42 and its effectors in regulating this degradation pathway.

Area of Science:

  • Cellular signaling and signal transduction pathways.
  • Molecular mechanisms of protein degradation.
  • Regulation of receptor tyrosine kinases.

Background:

  • Ligand-induced degradation is crucial for regulating epidermal growth factor receptor (EGFR) signaling.
  • EGFRs undergo monoubiquitination, sorting via ubiquitin-interaction machinery, and lysosomal degradation post-activation.
  • The Rho-family small GTPase, Cdc42, is suggested to play a role in EGFR degradation.

Purpose of the Study:

  • To establish routine methods for assaying EGFR endocytosis and degradation.
  • To investigate the influence of Cdc42 on EGFR degradation.
  • To determine the effects of Cdc42's downstream targets, ACK and p85Cool-1/Pix, on EGFR degradation.

Main Methods:

  • Development of standard assays for monitoring EGFR endocytosis.
  • Establishment of protocols for quantifying EGFR degradation.
  • Procedures for assessing the impact of Cdc42 and its effectors (ACK, p85Cool-1/Pix) on EGFR degradation.

Main Results:

  • Validated methods for measuring EGFR endocytosis and degradation are presented.
  • The study provides a framework for analyzing the role of Cdc42 in EGFR degradation.
  • Procedures allow for the examination of specific downstream targets of Cdc42 in this process.

Conclusions:

  • The described methods facilitate the study of EGFR degradation regulation.
  • Cdc42 and its associated kinases (ACK, p85Cool-1/Pix) are key regulators of EGFR degradation.
  • This work provides tools to further elucidate the molecular mechanisms controlling EGFR signaling termination.